Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 
The feature you requested does not exist. However, we suggest the following feature:

Xenon Pharmaceuticals to Host Conference Call and Webcast Today at 9:00 a.m. Eastern Time to Discuss Topline Results from TV-45070 Phase 2b Clinical Trial in PHN

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/27/2017 | 02:18pm CEST

BURNABY, British Columbia, June 27, 2017 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, announced that it will host a conference call and live audio webcast at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time) today to discuss the topline results from the TV-45070 Phase 2b clinical trial in post-herpetic neuralgia (PHN).

A link to the live audio webcast of the presentation will be available on the investors section of Xenon's website at investor.xenon-pharma.com and will be available for replay following the event. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 47072480.

About Xenon Pharmaceuticals Inc.

Xenon is a clinical stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Building upon our extensive knowledge of human genetics and diseases caused by mutations in ion channels, known as channelopathies, we are advancing – both independently and with our pharmaceutical collaborators – a novel product pipeline of ion channel modulators to address therapeutic areas of high unmet medical need, such as pain and epilepsy. For more information, please visit www.xenon-pharma.com.

Investor/Media Contact:
Jodi Regts
VP, Corporate Affairs & Investor Relations
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: [email protected]

Primary Logo


© GlobeNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
02:18p XENON PHARMACEUTICALS TO HOST CONFERENCE CALL AND WEBCAST TODAY AT 9 : 00 a.m. Eastern Time to Discuss Topline Results from TV-45070 Phase 2b Clinical Trial in PHN
02:18p PREMIER GOLD MINES LTD. : Research Initiated on Basic Materials Stocks: Premier Gold Mines, Laramide Resources, Agnico Eagle Mines, and Lucara Diamond
02:17p DASSAULT SYSTEMES : PSA Retail Unveils its Digital In-Store Experience with Dassault Systemes
02:17p COMMERZBANK : #17-589 Listing of Mini futures issued by Commerzbank AG
02:17p WYNDHAM WORLDWIDE : Celebrate National Vacation Rental Month with Travel Deals from Wyndham Vacation Rentals
02:17p GLOBAL DECEPTION TECHNOLOGY MARKET TO GROW AT A CAGR OF 9.8% 2017-2021 : Analysis By Deployment Model, End User & Geography - Research and Markets
02:16p HIGHWAY 50 GOLD : NHP reports fatal crash on Highway 50 near Cave Rock at Lake Tahoe
02:16p Wingstop Creates Chief Experience Officer Role to Further Deliver World-Class Guest Experience
02:16p Kaminario Gains Significant Channel Momentum as Demand for its Innovative Storage Solution Accelerates
02:16p Morgridge scientists illuminate structures vital to virus replication
Latest news
Advertisement
Hot News 
-3.24%STADA ARZNEIMITTEL : Bain and Cinven takeover of Germany's Stada falls apart
-2.93%Schaeffler slashes profit guidance on steel costs, electric shift
-1.41%CROWN RESORTS : Casino Executive Sentenced -- WSJ
-3.37%DEBENHAMS : cautions UK trading more volatile as sales slide
1.35%TESCO : Investec Bank plc Form 8.5 (EPT/RI) - Tesco Plc
Most Read News
02:48aDJWARREN BUFFETT : Buffett Backs Store REIT -- WSJ
05:24a Oil up on weaker dollar, supply glut caps gain
07:01a Global stocks, dollar ease as central bank officials take centre stage
12:41a CARLOS GHOSN : Nissan says CEO Ghosn's salary rose 2.5 percent last year
02:48aDJDANIEL LOEB : Nestlé and L'Oréal Have Long History, Too Long for Loeb -- WSJ
Most recommended articles
08:15aDJS&P 500, Nasdaq Futures -- Technical Analysis
08:13aDJSAMSUNG ELECTRONICS : Revives Galaxy Note 7 With New 'Fandom Edition'
08:09a British grocers' sales growth at five-year high on rising food prices
08:09a In Amazon's shadow, hedge funds take aim at Brexit-hit retailers
08:08a Plunge in UK confidence hits Debenhams, adds to slowdown fears